ketoconazole has been researched along with oxiconazole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V | 1 |
| Chatterjee, PK; Sharma, S; Singh, SM | 1 |
| Cauwenbergh, G | 1 |
| Bastide, JM; Bastide, M; Jouvert, S; Lebecq, JC; Mallie, M; Montes, B | 1 |
| Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Phillips, SB; Potts, CE; Shelanski, MV | 1 |
| Lucky, AW; Ploysangam, T | 1 |
| Binet, O; Garrel, JB; Grossetête, G; Grosshans, E; Jeanpierre, G; Kalis, B; Privat, Y; Sonneck, JM; Souteyrand, P | 1 |
| Baji, H; Compagnon, PL; Delcourt, A; Flammang, M; Kimny, T; Mathieu, G | 1 |
| Orengo, I; Rosen, T; Schell, BJ | 1 |
| Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z | 1 |
| Bansal, S; Grover, C; Kumar, V; Nanda, S; Reddy, BS | 1 |
| Estève, E; Lagier, L; Machet, L; Poisson, DM | 1 |
1 review(s) available for ketoconazole and oxiconazole
| Article | Year |
|---|---|
Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature.
Topics: Allylamine; Antifungal Agents; Child; Child, Preschool; Ciclopirox; Coloring Agents; Female; Foot Dermatoses; Humans; Hydroxides; Imidazoles; Ketoconazole; Male; Mycology; Onychomycosis; Potassium Compounds; Pyridones; Tinea Pedis; Trichophyton | 1997 |
4 trial(s) available for ketoconazole and oxiconazole
| Article | Year |
|---|---|
Evaluation of cutaneous reactivity to recently marketed dermatologic products.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antifungal Agents; Calcitriol; Clobetasol; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Doxepin; Drug Prescriptions; Female; Humans; Hypersensitivity; Imidazoles; Irritants; Ketoconazole; Male; Metronidazole; Middle Aged; Mupirocin; Naphthalenes; Patch Tests; Pharmaceutical Vehicles; Placebos; Risk Factors; Skin; Terbinafine | 1996 |
[Oxiconazole cream versus ketoconazole cream. A prospective, randomized, double-blind, multicenter study in the treatment of inguinocrural dermatophytoses].
Topics: Administration, Topical; Antifungal Agents; Dermatomycoses; Double-Blind Method; Drug Tolerance; Groin; Humans; Imidazoles; Ketoconazole; Prospective Studies; Treatment Outcome | 1996 |
Anti-inflammatory activity of antifungal preparations.
Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Chemoprevention; Ciclopirox; Double-Blind Method; Econazole; Erythema; Female; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Male; Middle Aged; Naphthalenes; Pyridones; Terbinafine; Ultraviolet Rays | 1997 |
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bandages; Child; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Hand Dermatoses; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Nails; Onychomycosis; Recurrence; Treatment Failure; Treatment Outcome | 2007 |
11 other study(ies) available for ketoconazole and oxiconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2014 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits | 1990 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
[Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Cytoplasm; Econazole; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Spheroplasts; Triazoles | 1988 |
In vitro susceptibility studies with oxiconazole (Ro 13-8996).
Topics: Antifungal Agents; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses | 1984 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
New polyazole derivatives from 2-(2,4-dichlorophenyl)-1,3-dioxolane. Antifungal activity. Structure-activity relationships.
Topics: Antifungal Agents; Arthrodermataceae; Azoles; Candida; Dioxolanes; Dose-Response Relationship, Drug; Imidazoles; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Species Specificity; Structure-Activity Relationship | 1997 |
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells | 1999 |
[Outbreak of dermatophytosis in a high-level French judo team: prospective study 2006/2011. Efficacy of a therapeutic protocol introduced in 2004/2005].
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Dermatitis, Occupational; Disease Outbreaks; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; France; Humans; Imidazoles; Ketoconazole; Male; Martial Arts; Naphthalenes; Prospective Studies; Secondary Prevention; Terbinafine; Tinea; Treatment Outcome; Young Adult | 2012 |